Clinical Trials on Haemophilia A
Total 4963 results
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumTerminatedHemophilia A | Hemophilia BUnited States
-
Bioverativ Therapeutics Inc.Swedish Orphan Biovitrum; Syntonix Pharmaceuticals, Inc.Completed
-
PfizerTerminatedHemophilia A | Hemophilia BUnited States
-
PfizerCompletedHemophilia A | Hemophilia B
-
CSL BehringCompletedHemophilia BUnited States, Japan, Israel, Austria, Bulgaria, France, Germany, Italy, Russian Federation, Spain
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia B | Hemophilia
-
PfizerCompletedHemophilia BUnited States, Spain, Croatia, Serbia, Russian Federation, Canada, Hungary, Italy, Romania
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Hospices Civils de LyonRecruiting
-
BiocadRecruitingStudy of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)Hemophilia BRussian Federation
-
St. Jude Children's Research HospitalNot yet recruiting
-
Bahçeşehir UniversityRecruitingHemophilia A | Hemophilia BTurkey
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
Institute of Hematology & Blood Diseases HospitalRecruiting
-
PfizerRecruitingHemophilia A | Hemophilia BHong Kong, Spain, Serbia, Turkey, United States, China, Mexico, South Africa, India, Japan, Croatia, Korea, Republic of, Oman, Taiwan, Italy, Canada, France
-
McMaster UniversityRecruiting
-
CSL BehringActive, not recruiting
-
PfizerActive, not recruitingHemophilia A | Hemophilia BUnited States, Canada, Spain, Australia, Korea, Republic of, Taiwan, Brazil, Italy, Japan, Turkey, Germany, United Kingdom, Saudi Arabia, France, Sweden, Belgium, Greece, Israel
-
CSL BehringEnrolling by invitation
-
PfizerActive, not recruitingHemophilia BUnited States, Canada, Australia, Turkey
-
McMaster UniversityEnrolling by invitationWeb Accessible Population Pharmacokinetics Service - Hemophilia: Sources of Variability (WAPPS-Hemo)Hemophilia A | Hemophilia BCanada
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompleted
-
CSL BehringCompletedHemophilia BUnited States, Australia, Japan, France, Philippines, Spain, Czechia, Israel, Canada, Germany, Austria, Bulgaria, Italy, Malaysia, South Africa
-
Baxalta now part of ShireCompletedHemophilia BRussian Federation, Ukraine, India, Poland, Romania, United Kingdom
-
OPKO Health, Inc.CompletedHemophilia A | Hemophilia BUnited States
-
Baxalta now part of ShireCompletedHemophilia BTaiwan, Colombia, Argentina, Brazil, Bulgaria, Chile, Czechia, India, Ireland, Italy, Japan, Poland, Romania, Russian Federation, Sweden, Ukraine, United Kingdom
-
Medexus Pharma, Inc.TerminatedHemophilia BUnited States, United Kingdom, India
-
National Taiwan University HospitalUnknown
-
Grifols Biologicals, LLCCompleted
-
Cangene CorporationWithdrawnHemophilia BUnited Kingdom, United States
-
PfizerCompleted
-
CSL BehringCompletedHemophilia BBulgaria, Israel
-
BayerCompletedHemophilia A | Hemophilia BSouth Africa, Poland, United Kingdom
-
PfizerCompletedHemophilia BKorea, Republic of
-
Weill Medical College of Cornell UniversityUniversity of Pennsylvania; CSL BehringCompletedHemophilia A | Hemophilia BUnited States, Puerto Rico
-
Weill Medical College of Cornell UniversityBayer; University Hospital, BonnCompletedHemophilia A | Hemophilia BUnited States, Israel, Australia, Italy, Sweden, Germany, Japan, Netherlands, Taiwan
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia BBelgium, Spain, Italy, Austria, United Kingdom, Netherlands, Sweden, Germany, Portugal, France
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia A | Hemophilia B
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Prothya BiosolutionsCompletedHemophilia BNetherlands
-
Catalyst BiosciencesTerminatedFactor VII Deficiency | Hemophilia A With Inhibitor | Glanzmann ThrombastheniaUnited States, India, Italy, Russian Federation, Ukraine
-
St. Jude Children's Research HospitalRecruitingHemophilia B | Gene TherapyUnited States
-
Baxalta now part of ShireActive, not recruiting
-
Ultragenyx Pharmaceutical IncCompletedHemophilia BUnited States, United Kingdom
-
Baxalta now part of ShireCompletedHemophilia A | Hemophilia BUnited States, Spain, Italy, Germany, France, Austria
-
Spark TherapeuticsChildren's Hospital of Philadelphia; University of Pittsburgh; St. James's Hospital... and other collaboratorsTerminated